塞力斯(603716.SH):擬受讓上海塞力斯49%股權並增資
格隆匯 8 月 3日丨塞力斯(603716.SH)公佈,公司擬根據注冊資本出資額平價受讓公司控股51%的上海塞力斯原小股東合計持有的49%股權;因上海塞力斯目前註冊資本尚未實繳,公司此次受讓對價為0元;股權受讓完成後,公司持有上海塞力斯100%股權。同時公司擬向上海塞力斯增資9000萬元,將註冊資本由原1000萬元增資至10000萬元。
公司擬藉助上海地區政策支持,以上海塞力斯為平台對擬開展的醫療集約化服務(IVD集約化和SPD業務)業務和擬拓展的“居家醫院”、“慢病管理”及“分級診療”運營管理中心等互聯網醫療業務佈局進行落地,但擴大醫療集約化業務開展具有不確定性,擬拓展的互聯網醫療業務尚處於較早期,業務落地機制尚未確定,可能存在落地緩慢、合作受阻及其他業務運營風險等諸多風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.